| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 65 |
| 1 | METHOTREXATE | 58 |
| 2 | FLUOROURACIL | 57 |
| 3 | FLUOROURACIL CREAM, 0.5% | 57 |
| 4 | OXALIPLATIN | 47 |
| 5 | CAPECITABINE | 39 |
| 6 | CYCLOPHOSPHAMIDE | 31 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 31 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 31 |
| 9 | BEVACIZUMAB | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 11 | 0.0040 |
| 1 | SEROTONIN | 1 | 0.0037 |
| 2 | THIOTEPA | 14 | 0.0014 |
| 3 | PANITUMUMAB | 16 | 0.0010 |
| 4 | RAMUCIRUMAB | 6 | 0.0009 |
| 5 | TAMOXIFEN CITRATE | 5 | 0.0009 |
| 6 | FLUOROURACIL CREAM, 0.5% | 57 | 0.0007 |
| 7 | FLUOROURACIL | 57 | 0.0007 |
| 8 | GINKGO BILOBA | 1 | 0.0007 |
| 9 | EVEROLIMUS TABLETS | 11 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 6 | 0.0009 |
| 1 | CD30-directed Immunoconjugate [EPC] | 6 | 0.0006 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 20 | 0.0004 |
| 3 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 90 | 0.0003 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 6 | Polyene Antifungal [EPC] | 10 | 0.0002 |
| 7 | Estrogen Receptor Antagonist [EPC] | 10 | 0.0002 |
| 8 | Platinum-based Drug [EPC] | 66 | 0.0002 |
| 9 | Alkylating Drug [EPC] | 51 | 0.0002 |